³Ô¹ÏÍøÕ¾

Latest lung cancer News | Page 5

Enhertu continues to demonstrate clinically meaningful tumour response
Tagrisso demonstrated 5.5-year median disease-free survival in adjuvant treatment of patients with EGFR-mutated lung cancer
Two QUT scientists honoured with Qld Young Tall Poppy Science Award
Scientists unlock potential for small cell lung cancer blood test
Enhertu approved in US as first HER2-directed therapy for patients with previously treated HER2-mutant metastatic non-small cell
Datopotamab deruxtecan-based combinations show promising clinical activity
Radiopharm Theranostics announces new agreements with Lantheus and NanoMab
Broadly diverse genomes study reveals new susceptibility genetic variants for lung cancer
Broadly diverse genomes reveals new susceptibility genetic variants for lung cancer
Curtin University study backs AWU’s alarm at extent of workplace silicosis health risk
10,000 Aussie workers set to develop lung cancer from silica dust: study
Mapping ‘energy fingerprints’ of lung cancer leads to fundamental treatment rethink
Top 3 questions – Men’s Health Week with Dr Lucas de Toca
Company fined over crystalline silica exposure risk
NSW Government must act swiftly on silica recommendations
Collaboration to jumpstart research
Promising anticancer molecule identified
“Being a man I looked at it and thought, I’ll be right”
Immutep reports positive overall response rate in lung cancer trial
1.4 million Australians will die of cancer in next 25 years without intervention
New research: 1.4 million Australians will die of cancer in next 25 years unless governments intervene now
Covid barriers to finding cancer early
Ludwig MSK study modeling tumor evolution reveals vulnerability for cancer prevention and therapy
Bonniefield champion raises $30,000 for cancer research
Workplaces encouraged to go smoke-free on World Day for Safety and Health
Enhertu granted Breakthrough Therapy Designation in US for patients with HER2-low metastatic breast cancer
Enhertu granted Priority Review in US for patients with previously treated HER2-mutant metastatic non-small cell lung cancer
Cancer Council calls on all political parties to reduce impact of cancer, as federal election campaign gets firmly underway
International partnership may hold key to new cancer therapies
Cannabis causes more cancers than tobacco
Dorothy Keefe reappointed as CEO
AstraZeneca aims to transform oncology treatment landscape with diverse early pipeline and novel combinations
Enzyme could be new target for cancer immunotherapies
Backing Cancer Research To Save Lives
Pharmac deal good news for New Zealanders
Rise of asbestos found in imported bee smokers
Flood victims urged to beware of asbestos exposure during clean-up
Companies fined after workers exposed to asbestos
Premature birth linked to lung disease later in life
Ovarian cancer’s advance slowed by drug
Closing Cancer Care Gap For All Victorians
World Cancer Day: Thousands of Australian workers die from occupational cancer every year
$2.5M grant awarded to flip switch on lung cancer drug resistance
New study highlights major deficiencies in lung cancer care in Australia
First patient dosed in phase I/IIa trial of lung cancer immunotherapy vaccine
Prostate cancer in Australia – what do numbers tell us?
PBS listing for BRAFTOVI + cetuximab for metastatic bowel cancer patients with BRAFV600 mutation
Reducing copper alters breast cancer metabolism